Cargando…

Natural Non-Trasgenic Animal Models for Research in Alzheimer’s Disease

The most common animal models currently used for Alzheimer disease (AD) research are transgenic mice that express a mutant form of human Aβ precursor protein (APP) and/or some of the enzymes implicated in their metabolic processing. However, these transgenic mice carry their own APP and APP-processi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarasa, Manuel, Pesini, Pedro
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825666/ https://www.ncbi.nlm.nih.gov/pubmed/19355852 http://dx.doi.org/10.2174/156720509787602834

Ejemplares similares

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease
por: Allué, José Antonio, et al.
Publicado: (2016)

Neprilysin Is Poorly Expressed in the Prefrontal Cortex of Aged Dogs with Cognitive Dysfunction Syndrome
por: Canudas, Jesús, et al.
Publicado: (2014)

Natural stilbenes effects in animal models of Alzheimer’s disease
por: Freyssin, Aline, et al.
Publicado: (2019)

Brain pyrimidine nucleotide synthesis and Alzheimer disease
por: Pesini, Alba, et al.
Publicado: (2019)

The domestic cat as a natural animal model of Alzheimer’s disease
por: Chambers, James K., et al.
Publicado: (2015)

Current Animal Models of Alzheimer’s Disease: Challenges in Translational Research
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2014)

Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
por: Burnham, Samantha C, et al.
Publicado: (2020)

Animal Models of Alzheimer's Disease
por: Casadesus, Gemma, et al.
Publicado: (2011)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD
por: Pesini, Pedro, et al.
Publicado: (2012)

Effects of Acupuncture on Alzheimer's Disease in Animal-Based Research
por: Park, Sunjung, et al.
Publicado: (2017)

Safety, tolerability and immunogenicity of an active anti-Aβ(40) vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial
por: Lacosta, Ana-María, et al.
Publicado: (2018)

Total Aβ(42)/Aβ(40) ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
por: Doecke, James D., et al.
Publicado: (2020)

Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ(40) and Aβ(42) Peptides in Plasma
por: Pérez-Grijalba, Virginia, et al.
Publicado: (2016)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

The rat as an animal model of Alzheimer’s disease
por: Benedikz, Eirikur, et al.
Publicado: (2009)

Do we still need animals? Surveying the role of animal‐free models in Alzheimer’s and Parkinson’s disease research
por: Aerts, Liesbeth, et al.
Publicado: (2022)

Ocular Manifestations of Alzheimer's Disease in Animal Models
por: Parnell, Miles, et al.
Publicado: (2012)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

Editorial: Natural animal models of diseases
por: Capela e Silva, Fernando, et al.
Publicado: (2022)

Current state of research on non‐human primate models of Alzheimer’s disease
por: Li, Hong‐Wei, et al.
Publicado: (2019)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021)

Utility of Animal Models to Understand Human Alzheimer’s Disease, Using the Mastermind Research Approach to Avoid Unnecessary Further Sacrifices of Animals
por: Qin, Tian, et al.
Publicado: (2020)

Innate immunity in Alzheimer’s disease: the relevance of animal models?
por: Franco Bocanegra, Diana K., et al.
Publicado: (2017)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Research progress of natural products and their derivatives against Alzheimer’s disease
por: Liu, Jin-Ying, et al.
Publicado: (2023)

Amyloid Peptide Toxicity in an Animal Model of Alzheimer Disease
por: Gross, Liza
Publicado: (2007)

Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
por: Klohs, Jan, et al.
Publicado: (2014)

Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models
por: Kwan, Ping, et al.
Publicado: (2022)

Different phenotypes of microglia in animal models of Alzheimer disease
por: Wei, Yun, et al.
Publicado: (2022)

Animal models of Alzheimer’s disease: Applications, evaluation, and perspectives
por: Chen, Zhi-Ya, et al.
Publicado: (2022)

Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012)

Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease
por: Jeon, Seong Gak, et al.
Publicado: (2018)

Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer’s Disease
por: ELBini-Dhouib, Ines, et al.
Publicado: (2021)

The Impact of Hydroxytyrosol on the Metallomic-Profile in an Animal Model of Alzheimer’s Disease
por: Tabanez, Miguel, et al.
Publicado: (2023)

Complex role of chemokine mediators in animal models of Alzheimer's Disease
por: Martin, Elodie, et al.
Publicado: (2018)

Experimentally induced animal models for cognitive dysfunction and Alzheimer's disease
por: Rapaka, Deepthi, et al.
Publicado: (2022)

Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
por: Martinez, Bridget, et al.
Publicado: (2019)

Brain Representation of Animal and Non-Animal Images in Patients with Mild Cognitive Impairment and Alzheimer’s Disease
por: Marefat, Haniyeh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1lqfpr7tr01f4gcbmeuvjmj1n0